Product Images Sumatriptan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Sumatriptan NDC 33261-663 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - sumatriptan usp 1
Figure 1. Estimated Probability of Achieving Initial Headache Response Within 4 Hours of Treatment in Pooled Trials 1, 2, and 3a - sumatriptan usp 2
Figure 2. The Estimated Probability of Patients Taking a Second Dose of Sumatriptan Tablets or Other Medication to Treat Migraine Over the 24 Hours Following the Initial Dose of Study Treatment in Pooled Trials 1, 2, and 3a - sumatriptan usp 3
Estimated Probability of Remedication or Rescue: 100% based on the dosage and type of medication used. The text also includes a table with different dosages of medication, including a placebo option. The last line of the text appears to be cut off and is not readable.*
Image Description - sumatriptan usp 4
This appears to be information about a medication called "Sumatriptan, USP" in different dosages and forms including a spray and tablet. The medication is also referred to as a generic for "Imitrex" and is made by a company named Aurbindo Pharma Ltd. It is unclear what the medication is used for or the potential side effects as the provided text is incomplete and difficult to understand in places due to errors.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.